AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23422351 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance Counseling group (n = 64) received exercise counseling via telephone for 6 months, along with print materials and feedback reports.
Number of subjects: 130
Study 23422351 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance Counseling group (n = 64) received exercise counseling via telephone for 6 months.
Number of subjects: 130
Study 23422351 — intervention group
Group type: COMPARATOR
Intervention: Contact Control group (n = 66) received contact control.
Number of subjects: 130
Study 23422351 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups were assessed for overall mental health.
Number of subjects: 130
Study 21555790 — intervention group
Group type: EXPERIMENTAL
Intervention: Drowsy/Sleeping state
Number of subjects: 100
Study 21555790 — intervention group
Group type: COMPARATOR
Intervention: Awake state
Number of subjects: 100
Study 19969208 — intervention group
Group type: EXPERIMENTAL
Intervention: +3.0 D IOL
Number of subjects: 279
Study 19969208 — intervention group
Group type: EXPERIMENTAL
Intervention: +4.0 D IOL
Number of subjects: 279
Study 17429917 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddled condition
Number of subjects: 0
Study 17429917 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-swaddled condition
Number of subjects: 0
Study 17429917 — intervention group
Group type: COMPARATOR
Intervention: Non-swaddled infants
Number of subjects: 0
Study 17429917 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddled infants (both conditions)
Number of subjects: 0
Study 15533341 — intervention group
Group type: EXPERIMENTAL
Intervention: Midluteal phase endometrial sampling
Number of subjects: 0
Study 15533341 — intervention group
Group type: EXPERIMENTAL
Intervention: Late luteal phase endometrial sampling
Number of subjects: 0
Study 12029922 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based asthma clinic project
Number of subjects: 0
Study 9040543 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-dense milk cereal formula (5 kJ/g, 11% protein)
Number of subjects: 75
Study 9040543 — intervention group
Group type: COMPARATOR
Intervention: Control group (milk-cereal formula with 2.5 kJ/g, 11% protein)
Number of subjects: 75
Study 7944321 — intervention group
Group type: EXPERIMENTAL
Intervention: Preadmission teaching brochures
Number of subjects: 38
Study 3059793 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant bean flakes
Number of subjects: 6
Study 3059793 — intervention group
Group type: COMPARATOR
Intervention: Potato-flakes bran
Number of subjects: 6
Study 3059793 — intervention group
Group type: EXPERIMENTAL
Intervention: Both meals
Number of subjects: 6
Study 30590877 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2-g LCPUFA-ω3 daily for 3 months
Number of subjects: 366
Study 30590877 — intervention group
Group type: COMPARATOR
Intervention: 1-g sunflower oil daily for 3 months (Control)
Number of subjects: 366
Study 28825998 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert system feedback tool
Number of subjects: 27
Study 25399016 — intervention group
Group type: EXPERIMENTAL
Intervention: First home BP measurement
Number of subjects: 4802
Study 25399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple home BP measurement days (1-7 days)
Number of subjects: 4802
Study 25399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Single home BP measurement
Number of subjects: 4802
Study 25399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven home measurement days
Number of subjects: 4802
Study 25399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked hypertension
Number of subjects: 4802
Study 25399016 — intervention group
Group type: EXPERIMENTAL
Intervention: White-coat hypertension
Number of subjects: 4802
Study 23306796 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical antrum resection (RA group)
Number of subjects: 12
Study 23306796 — intervention group
Group type: COMPARATOR
Intervention: Preserved antrum (PA group, control)
Number of subjects: 12
Study 20801942 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic treatment programme (experimental group)
Number of subjects: 15
Study 20801942 — intervention group
Group type: COMPARATOR
Intervention: Routine occupational therapy (control group)
Number of subjects: 15
Study 18455411 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart-lung machine (HLM)
Number of subjects: 32
Study 18455411 — intervention group
Group type: COMPARATOR
Intervention: Non-heart-lung machine (non-HLM)
Number of subjects: 32
Study 18455411 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall psychological score
Number of subjects: 32
Study 17375319 — intervention group
Group type: EXPERIMENTAL
Intervention: Early onset cognitive behavioural therapy
Number of subjects: 171
Study 17375319 — intervention group
Group type: COMPARATOR
Intervention: Control group (no early onset cognitive behavioural therapy)
Number of subjects: 171
Study 14737168 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 hours of nocturnal sleep
Number of subjects: 0
Study 14737168 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal wakefulness
Number of subjects: 0
Study 14737168 — intervention group
Group type: COMPARATOR
Intervention: Daytime wakefulness
Number of subjects: 0
Study 11890581 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (home hazard assessment, educational strategy, installation of safety devices)
Number of subjects: 570
Study 11890581 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (advice on modifying specific hazards)
Number of subjects: 570
Study 11890581 — intervention group
Group type: EXPERIMENTAL
Intervention: General education message
Number of subjects: 570
Study 9597214 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrow (FlexTip Plus) epidural catheter
Number of subjects: 200
Study 9597214 — intervention group
Group type: COMPARATOR
Intervention: Portex epidural catheter
Number of subjects: 200
Study 8163375 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery training
Number of subjects: 40
Study 8163375 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback
Number of subjects: 40
Study 8163375 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 3796926 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 52
Study 3796926 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 52
Study 31424399 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor therapeutic garden (TG)
Number of subjects: 163
Study 29029087 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 114
Study 29029087 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan
Number of subjects: 114
Study 26903197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (PRD)
Number of subjects: 64
Study 26903197 — intervention group
Group type: COMPARATOR
Intervention: Saline (PRS)
Number of subjects: 64
Study 25386453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (200 μg/kg body weight) oral in a single dose
Number of subjects: 240
Study 25386453 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Permethrin 5% cream single application
Number of subjects: 240
Study 25386453 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical gamma benzene hexachloride (GBHC) lotion 1% single application
Number of subjects: 240
Study 25386453 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Benzyl benzoate (BB) lotion 25% single application
Number of subjects: 240
Study 23033919 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement (120 mg of N-oleyl-phosphatidyl-ethanolamine and 105 mg of epigallocatechin-3-gallate)
Number of subjects: 50
Study 23033919 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement
Number of subjects: 50
Study 23033919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19944377 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Education Program (PEP)
Number of subjects: 40
Study 19944377 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care (Control)
Number of subjects: 40
Study 17324047 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-mg cortisol
Number of subjects: 44
Study 17324047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 14967159 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants (vitamins C and E, beta-carotene, selenium) with methimazole
Number of subjects: 57
Study 14967159 — intervention group
Group type: COMPARATOR
Intervention: Methimazole only
Number of subjects: 57
Study 14967159 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants with methimazole
Number of subjects: 57
Study 11458213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal irrigation with bulb syringe
Number of subjects: 150
Study 11458213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal irrigation with nasal irrigation pot
Number of subjects: 150
Study 11458213 — intervention group
Group type: COMPARATOR
Intervention: Reflexology massage
Number of subjects: 150
Study 11458213 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (bulb syringe, nasal irrigation pot, reflexology massage)
Number of subjects: 150
Study 9568442 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy for H. pylori
Number of subjects: 236
Study 9568442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 8092559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate 200 micrograms once daily
Number of subjects: 365
Study 8092559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate 100 micrograms twice daily
Number of subjects: 365
Study 8092559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate (both dosages)
Number of subjects: 365
Study 8092559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365
Study 8092559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fluticasone propionate (200 micrograms once daily or 100 micrograms twice daily)
Number of subjects: 365
Study 2964468 — intervention group
Group type: EXPERIMENTAL
Intervention: Life review process (experimental group)
Number of subjects: 60
Study 2964468 — intervention group
Group type: COMPARATOR
Intervention: Friendly visit (control group)
Number of subjects: 60
Study 2964468 — intervention group
Group type: COMPARATOR
Intervention: No treatment (no-treatment group)
Number of subjects: 60
Study 31774604 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 40
Study 31774604 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 40
Study 31188852 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol intervention trials
Number of subjects: 27
Study 28375713 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G spinal needle
Number of subjects: 84
Study 28375713 — intervention group
Group type: COMPARATOR
Intervention: 29G spinal needle
Number of subjects: 84
Study 25885543 — intervention group
Group type: EXPERIMENTAL
Intervention: Qishe pill (3.75 grams)
Number of subjects: 108
Study 25885543 — intervention group
Group type: EXPERIMENTAL
Intervention: Qishe pill (7.5 grams)
Number of subjects: 108
Study 25885543 — intervention group
Group type: EXPERIMENTAL
Intervention: Qishe pill (15 grams)
Number of subjects: 108
Study 24006953 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold chain rotigotine patch (2 mg/24 h) in SP951
Number of subjects: 158
Study 24006953 — intervention group
Group type: COMPARATOR
Intervention: Original rotigotine patch (2 mg/24 h) in SP951
Number of subjects: 158
Study 24006953 — intervention group
Group type: EXPERIMENTAL
Intervention: Room temperature stable rotigotine patch (2 mg/24 h) in SP0987
Number of subjects: 158
Study 24006953 — intervention group
Group type: COMPARATOR
Intervention: Cold chain rotigotine patch (2 mg/24 h) in SP0987
Number of subjects: 158
Study 24006953 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold chain rotigotine patch (8 mg/24 h) in SP1066
Number of subjects: 158
Study 24006953 — intervention group
Group type: COMPARATOR
Intervention: Room temperature stable rotigotine patch (8 mg/24 h) in SP1066
Number of subjects: 158
Study 21835022 — intervention group
Group type: EXPERIMENTAL
Intervention: True diet (n = 84)
Number of subjects: 167
Study 21835022 — intervention group
Group type: COMPARATOR
Intervention: Sham diet (n = 83)
Number of subjects: 167
Study 19637968 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline plus 6% dextran70 (HSD)
Number of subjects: 64
Study 19637968 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (NS)
Number of subjects: 64
Study 17460547 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 174
Study 15181134 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroglobulin (Tg) levels measured just before (131)I ablative therapy (Tg1)
Number of subjects: 212
Study 15181134 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroglobulin (Tg) levels measured 6-12 months later (Tg2)
Number of subjects: 212
Study 15181134 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease progression
Number of subjects: 212
Study 15181134 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression-free survival rates
Number of subjects: 212
Study 15181134 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate analysis of disease progression
Number of subjects: 212
Study 15181134 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate analysis of disease progression
Number of subjects: 212
Study 15181134 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial parameters for disease progression
Number of subjects: 212
Study 10552274 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5% carbohydrate (CHO) solution
Number of subjects: 10
Study 10552274 — intervention group
Group type: COMPARATOR
Intervention: Artificially sweetened placebo (Pl)
Number of subjects: 10
Study 9323144 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy and continuous-course radiotherapy (Arm B)
Number of subjects: 100
Study 9323144 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (Arm A)
Number of subjects: 100
Study 8457239 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide (200 mg suppository, t.i.d. for 2 days)
Number of subjects: 39
Study 8457239 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (500 mg suppository, t.i.d. for 2 days)
Number of subjects: 39
Study 3533007 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent moisture vapor permeable dressing (MVP)
Number of subjects: 48
Study 3533007 — intervention group
Group type: COMPARATOR
Intervention: Gauze and tape dressing
Number of subjects: 48
Study 3533007 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dressings
Number of subjects: 48
Study 30397939 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day Cefuroxime prophylaxis
Number of subjects: 450
Study 30397939 — intervention group
Group type: COMPARATOR
Intervention: 3-day Cefuroxime prophylaxis
Number of subjects: 450
Study 30397939 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 450
Study 26423100 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-play video games (Xbox 360 with Kinect)
Number of subjects: 16
Study 25044909 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry-containing baked products
Number of subjects: 10
Study 25044909 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprocessed blueberry drink
Number of subjects: 10
Study 25044909 — intervention group
Group type: COMPARATOR
Intervention: Matched control baked products
Number of subjects: 10
Study 22452233 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight necktie
Number of subjects: 40
Study 22452233 — intervention group
Group type: EXPERIMENTAL
Intervention: Loosening necktie
Number of subjects: 40
Study 22452233 — intervention group
Group type: COMPARATOR
Intervention: No necktie
Number of subjects: 40
Study 20405515 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone monotherapy (MpMT) (32 mg/m2/day IV x 3 days)
Number of subjects: 30
Study 20405515 — intervention group
Group type: COMPARATOR
Intervention: Control group (children without peripheral blasts)
Number of subjects: 30
Study 18184901 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg
Number of subjects: 62
Study 18184901 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 62
Study 18184901 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 62
Study 18184901 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg
Number of subjects: 62
Study 18184901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 15781794 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP) with Soffodex
Number of subjects: 329
Study 15781794 — intervention group
Group type: COMPARATOR
Intervention: Non-mechanical bowel preparation (non-MBP)
Number of subjects: 329
Study 15781794 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 329
Study 15781794 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 329
Study 12557835 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (MQ)
Number of subjects: 115
Study 12557835 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine-artesunate (MQ-AS)
Number of subjects: 115
Study 10943959 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice‐ORS (R‐ORS)
Number of subjects: 466
Study 10943959 — intervention group
Group type: COMPARATOR
Intervention: Glucose‐ORS (G‐ORS)
Number of subjects: 466
Study 8922914 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based stress management training (10-week relaxation-based programme)
Number of subjects: 100
Study 8922914 — intervention group
Group type: COMPARATOR
Intervention: Normal care (control group)
Number of subjects: 100
Study 1583307 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 486 (200 mg orally, 48 hours before Sulprostone injection)
Number of subjects: 50
Study 1583307 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RU 486)
Number of subjects: 50
Study 1583307 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 486 treatment
Number of subjects: 50
Study 3931509 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 62
Study 3931509 — intervention group
Group type: COMPARATOR
Intervention: Antihistamine
Number of subjects: 62
Study 31806216 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 mg twice daily)
Number of subjects: 2725
Study 31806216 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (150 mg twice daily)
Number of subjects: 2725
Study 31806216 — intervention group
Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study 29506909 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (HFD) containing 45% fat for 6 weeks
Number of subjects: 92
Study 27367614 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based tools combined with phone-based intervention (TECH + PHONE)
Number of subjects: 80
Study 27367614 — intervention group
Group type: COMPARATOR
Intervention: Standard self-monitoring tools (ST)
Number of subjects: 80
Study 27367614 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based self-monitoring tools (TECH)
Number of subjects: 80
Study 27367614 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based self-monitoring tools (TECH) and Technology-based tools combined with phone-based intervention (TECH + PHONE)
Number of subjects: 80
Study 25380994 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based lay health workers (LHWs) supporting hypertension management in intervention clinics.
Number of subjects: 0
Study 25380994 — intervention group
Group type: COMPARATOR
Intervention: Usual care in control clinics.
Number of subjects: 0
Study 23348641 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sedation (G1) with propofol (1mg/kg) and continuous infusion of propofol (25‐50mg/kg/min) and remifentanil (0.01‐0.05 mg / kg / min)
Number of subjects: 32
Study 23348641 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (G2) with propofol (2mg/kg) and continuous infusion of propofol (60‐100mg/kg/min) and remifentanil (0.06 to 0.1g/kg/min)
Number of subjects: 32
Study 20486868 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 6 months
Number of subjects: 20
Study 20486868 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 20
Study 20486868 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 6 months in women without RAAS blockade
Number of subjects: 20
Study 20486868 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 6 months in women with RAAS blockade
Number of subjects: 20
Study 19064745 — intervention group
Group type: EXPERIMENTAL
Intervention: ethyl‐EPA, 1 g twice a day
Number of subjects: 316
Study 19064745 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 316
Study 19064745 — intervention group
Group type: EXPERIMENTAL
Intervention: ethyl‐EPA (open-label phase)
Number of subjects: 316
Study 15955148 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive spirometry (IS) for 2 months with medical treatment
Number of subjects: 27
Study 15955148 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment only
Number of subjects: 27
Study 11133786 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drop condition (voluntary interaction with vestibulo-collic reflex)
Number of subjects: 24
Study 11133786 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive drop condition (no voluntary interaction)
Number of subjects: 24
Study 11133786 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-surgery condition (after selective peripheral denervation of neck muscles)
Number of subjects: 24
Study 11133786 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatosensory/auditory voluntary reaction times in SCM
Number of subjects: 24
Study 11133786 — intervention group
Group type: EXPERIMENTAL
Intervention: Latency of the startle reflex
Number of subjects: 24
Study 9562208 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus Mianserin
Number of subjects: 34
Study 9562208 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine plus Placebo
Number of subjects: 34